https://research.ouhsc.edu/news Parent Page: News id: 26727 Active Page: details id: 26917

News

OUHSC Research News – Monday, July 25, 2022


Published: Friday, July 22, 2022

OUHSC Research News – Monday, July 25, 2022

Notices and Reminders

SoonerTrack II Announcement

The Office of Research Administration (ORA) is pleased to announce that the SoonerTrack II system is now fully operational! All proposals must be routed through the new system for review, institutional approval, and submission to the sponsor.  The launch webpage for the system is https://fs.ou.edu. User guides and training materials are available at https://research.ouhsc.edu/research-administration/soonertrack-ii-support.  If you have any questions, please contact soonertrackhelpdesk@ouhsc.edu.

 

Important SoonerTrack Update

**Please note that to be added to routing forms as Principal Investigator (PI) or personnel, you must log into https://fs.ou.edu as soon as possible. Other than logging in and out, you do not need to do anything else at this time. However, if you do not perform this initial login step, your department support will not be able to route forms for you nor will other researchers be able to add you to their projects in SoonerTrack.

If you are routing a proposal/agreement in SoonerTrack II and can’t find your department, please contact your business administrator. If you have any questions, please contact us at soonertrackhelpdesk@ouhsc.edu.

 

**As of Monday, July 18, 2022, all the tickets that were in active or pending ORA review statuses in old SoonerTrack are accessible in SoonerTrack II (new system).  While this will include most document types, Subawards and Independent Contract Agreements (ICAs) will be added separately and at a later date. If you are unable to find a ticket in the new system, please contact soonertrackhelpdesk@ouhsc.edu. 

Please be aware that as the conversion was a huge task, there are a few kinks we are working through.  As noted, if you experience issues, please contact your ORA Sponsored Programs Administrator or Contract Administrator or reach out to the Help Desk.

 

SoonerTrack II Training Opportunities

Pre-scheduled SoonerTrack II training sessions are available at the following dates and times. All sessions are the same, so register for the one that best fits your schedule. Additional dates will be provided as needed (These sessions will be conducted via Zoom).  

  • Thursday, July 28, 2022, 10:00 AM – 11:00 AM- Register here

 

The Office of Vice President for Research (OVPR) and the Office of Research Administration (ORA) at the OU Health Sciences Center Announcing the Launch of the Newly Redesigned Website

We are excited to announce the launch of our newly redesigned website. The new design allows for streamlined menus and clear navigation, and offers quick and easy access to essential information for our faculty and staff. Explore the website at https://research.ouhsc.edu. We welcome your feedback. Please send any questions or comments to oradmin@ouhsc.edu.

 

NIH Reminder: All NIH-funded clinical trials are expected to register and submit results information to Clinicaltrials.gov, as per the “NIH Policy on Dissemination of NIH-Funded Clinical Trial Information for competing applications and contract proposals. The requirements for registration and results reporting are:

  • Recipients must ensure that their NIH-funded clinical trials are registered at ClinicalTrials.gov for public posting no later than 21 days after enrollment of the 1st participant.
  • Results information must be submitted to ClinicalTrials.gov no later than one year after primary completion date (with limited exceptions).

If your RPPR has associated clinical trials that do not comply with these requirements, you may receive errors that prevent the RPPR from being submitted.

 

NIH Notice: eRA Retirement of All Application Form Versions Prior to FORMS-E (NOT-OD-22-182) 

The purpose of this notice is to inform the applicant community that eRA Application Submission System and Interface for Submission Tracking (ASSIST) will no longer support all application form versions prior to FORMS-E by the end of August 2022.  https://grants.nih.gov/grants/guide/notice-files/NOT-OD-22-182.html

 

Workshops and Seminars

Webinar I: Understanding the New NIH Data Management and Sharing Policy 

Date: Thursday, August 11, 1/24/22, 12:30 - 2:30 PM (Central)

Description: The NIH Office of Science Policy (OSP) and the Office of Extramural Research (OER) invite you to join them for an engaging and interactive webinar focused on the new DMS policy which goes into effect on January 25, 2023. In this webinar, you will learn about DMS policy expectations, the applicability of the policy, how to prepare a Data Management and Sharing Plan, and considerations for sharing data responsibly. Don't miss this valuable opportunity to hear from policy experts and get your questions answered. Registration: https://vfairs.zoom.us/webinar/register/WN_CtZuYKxtTeioXptg43JDgg

 

Webinar II: Diving Deeper into the New NIH Data Management and Sharing Policy 

Date: Thursday, September 22, 2022 / 12:30 - 2:30 PM (Central)

Description: The NIH Office of Science Policy (OSP) and the Office of Extramural Research (OER) invite you to join them for an engaging and interactive webinar focused on the new DMS policy which goes into effect on January 25, 2023. In this second webinar of the series, we will expand upon the information presented in the first webinar and dive deeper into topics including privacy protections for data from human participants and justifiable limitations on sharing data. Don't miss this valuable opportunity to hear policy experts provide the latest information and to get your questions answered.

Registration: https://vfairs.zoom.us/webinar/register/WN_3y9GFMc2SsWpv2GhIzOGsg

 

OUHSC Funding Opportunities

Presbyterian Health Foundation (PHF) Bridge Grant Program – Request For Applications

  • Cycle II PHF Bridge Grant Program Deadline: July 29, 2022

The primary objective of the PHF Bridge Grant Program is to provide funding to enhance OUHSC faculty competitiveness for extramural funding. OUHSC Principal Investigators are eligible if they meet the following criteria: 1) have submitted an extramural application within the past 18 months that was scored but not funded, 2) are requesting over $750,000 in total direct costs and over $200,000 in total facilities and administration (F&A) costs; and 3) received a review that ranks applications  and provides critiques. 

IMPORTANT UPDATE: This program can now provide funding for up to $100,000 for one year. SALARY and FRINGE BENEFITS may be requested for the Principal Investigator(s) up to $25,000 in total (salary + fringe benefits = $25,000) with the remaining portion, $75,000, used to support the project costs. Guidelines and Application Form are attached or can be found here.  If you have any questions, please email  VPR@ouhsc.edu

 

Office of Technology Commercialization presents the following opportunities for researchers to engage with industry (click here for more information, or email otc@ou.edu or gina-mcmillen@ouhsc.edu).  

  • Almirall, a global biopharmaceutical company focused on skin health, is seeking partnering opportunities is medical dermatology.  Of interest are target immune-inalfmmatory pathways with rationale for dermatological indications, non-melanoma skin cancer or rare dermatological indications.  Any therapeutic modality and all stages of development will be considered.  Out of scope:  drug delivery reformulations, natural products, aesthetic and cosmetic products.   Submission entails a 1-pg non-confidential summary of technology with optional supplemental information.  (deadline 08/05).
  • Mars Petcare is seeking fermentation technologies to transform raw materials and boost product flavor and attractiveness for cats and dogs.  Plant-based raw materials/substances and technologies with opportunity to up-cycle agricultural side stream and human food industry by products are of high interest.  Novel fermentation equipment/systems and bio-separation or purification technologies are also of interest provided they allow for fermentation or improve over existing processes.    Submission entails a 1-pg non-confidential summary of technology with optional supplemental information.  (deadline 08/12).
  • The sustainable materials division of Faurecia, a tier-one automotive supplier interested in developing low carbon footprint alternative skins/leather/textiles, is seeking sustainable leather substitutes to decrease emission factors of interior parts.  All kinds of subsitutes or feedstock are of interest. Submission entails a 1-pg non-confidential summary of technology with optional supplemental information.  (deadline 08/12).

 

 NIH Notices 

 

NOTE: When only one application is allowed per Institution according to the sponsor instructions, a one-page letter of intent summarizing the proposed project should be submitted to the Vice President for Research at least two months prior to the application deadline (unless otherwise noted).  The letters of intent will be reviewed and a single application will be chosen for submission from the University.

 

NIH Funding Opportunities

 

Other Funding Opportunities

The Melanoma Research Alliance (MRA) - Patient-Centric Clinical Trial Team Science Awards

Description: The Melanoma Research Alliance (MRA) is pleased to announce a Special Opportunity RFP for Team Science Awards focused on patient-centric clinical trials, jointly funded by The Rising Tide Foundation for Clinical Cancer Research (RTFCCR) and MRA. MRA and RTFCCR will jointly support two team awards (each up to $1.5 million) for clinical trials with the potential to provide significant impact to melanoma patients. These awards seek to support novel, interventional clinical trials with the goal of making a significant difference to melanoma patients in the short term. Patient engagement must be actively demonstrated throughout the full life cycle of the clinical trial, including planning and dissemination.

Informational webinars: Informational webinars will be offered on July 26 at 9 am ET & July 28 at 11 AM ET. Applicants are highly encouraged to attend

Letters of Intent Due: October 5, 2022

Invited Full Proposals Due: January 18, 2023

Link to Full Announcement: CureMelanoma.org/RFP

 

Susan G. Komen Career Catalyst Research (CCR) Grants - call for research proposals from early career investigators

Description: For more than a decade Susan G. Komen Career Catalyst Research (CCR) Grants have fostered promising breast cancer researchers who are in the early stages of their faculty careers, conducting research that has unlocked new knowledge about breast cancer and helped advance patient care.  Through this grant mechanism, we seek to support those who will emerge as the next generation of key leaders in the quest to end breast cancer.  Eligibility: Junior faculty members working at academic institutions in the United States who have not held any faculty appointment for more than a total of six years are invited to apply for our Career Catalyst Research Grants. 

Letters of Intent Deadline: Extended to August 1, 2022
Full Application Due: October 5, 2022

Link to Full Announcement: https://bit.ly/3xmfvcn

 

Oklahoma Center for Adult Stem Cell Research (OCASCR)

Description: The overall goal of OCASCR is to help adult stem cell and regenerative medicine research thrive in Oklahoma and to serve as a trusted resource for public information on these topics. Grants are accepted for research, equipment, and travel/education, and other areas.

Application Deadline: September 20, 2022

Link to Full Announcement: http://www.ocascr.org/grants/

 

The International Center for Responsible Gaming - Small Grants for Research on Lottery Gambling

Description: The International Center for Responsible Gaming and the Hoosier Lottery are collaborating on a special initiative to encourage research on responsible gambling as it relates to lottery gambling. Research projects may include but are not limited to: 

  • Stand-alone research projects or a pilot project; 
  • Preliminary research in preparation for a large research project, such as a comprehensive literature review, or instrument development and testing; and 
  • Research tasks subsequent to a full research project, such as follow-up testing. 

Applicants may request up to $25,000 in direct costs and $5,000 in Facilities and Administration costs

Application Deadline: September 1, 2022

Link to Full Announcement: https://www.icrg.org/research-center/apply-icrg-funding

 

The Oklahoma Center for the Advancement of Science and Technology (OCAST)  Notice of Funding Opportunity Announcements. OCAST has published a list of Funding Opportunity Announcements for FY 2022. The guidelines for 2022 have not been released yet. Next application submission period opens on August 15, 2022 and closes September 26, 2022. More information about the funding opportunity announcements and additional resources are available here: https://oklahoma.gov/ocast/ogx-overview/funding-opportunities.html.

 

The Cystic Fibrosis Foundation (CFF): Biological Basis for CF-Related Diabetes Program

Description: The intent of this request for applications is to solicit and fund projects that will improve our understanding of the biological basis for the development and progression of cystic fibrosis-related diabetes as well as to identify potential novel therapeutic strategies to manage and treat the disease. 

Application deadline: August 2, 2022

Link to Full Announcement: https://www.cff.org/researchers/biological-basis-cf-related-diabetes-program

 

DoD FY22 Breast Cancer Research Program (BCRP)

  • Breakthrough Award Levels 1 and 2 II (BTA12-2)
  • Era of Hope Scholar Award II (EOHS-2)

Pre-Application (Letter of Intent): September 22, 2022
Application: October 6, 2022 

  • Breakthrough Award Level 3 II (BTA3-2)
  • Breakthrough Award Level 4 II (BTA4-2)
  • Innovator Award II (INNOV-2)
  • Transformative Breast Cancer Consortium Award II (TBCCA-2)

Pre-Application (Preproposal): August 3, 2022
Invited Application: November 2, 2022

Link to Full Announcement: https://cdmrp.army.mil/funding/bcrp

 

DoD FY22 Melanoma Research Program (MRP)

  • Melanoma Academy Scholar Award (MASA)
  • Mid-Career Accelerator Award (MCAA)
  • Team Science Award (TSA)
  • Focused Program Award – Rare Melanomas (FPA)

Pre-Application (Letter of Intent): September 14, 2022
Application: October 5, 2022

Link to Full Announcement: https://cdmrp.army.mil/funding/mrp

 

DoD FY22 Lupus Research Program (LRP)

  • Idea Award (IA)
  • Impact Award (IPA)
  • Transformative Vision Award (TVA)

Pre-Application (Letter of Intent): August 16, 2022
Application: September 1, 2022

Link to Full Announcement: https://cdmrp.army.mil/funding/lrp

 

DoD FY22 Prostate Cancer Research Program (PCRP)

  • Translational Science Award (TSA)
  • Health Disparity Research Award (HDRA)
  • Data Science Award (DSA)

Pre-Application (LOI): August 4, 2022

Application: August 25, 2022

Link to Full Announcement: https://cdmrp.army.mil/funding/pcrp

 

DoD FY22 Peer Reviewed Cancer Research Program (PRCRP)

  • Convergent Science Cancer Consortium Development Award (CSCCDA)

Pre-Application (Letter of Intent): August 17

Application: September 7, 2022

Link to Full Announcement: https://cdmrp.army.mil/funding/prcrp

 

MIT Solve/The Bill and Melinda Gates Foundation

Description: MIT Solve, in collaboration with the Bill & Melinda Gates Foundation, seeks solutions that will offer new ways of measuring primary health care performance improvement in low- and middle-income countries. Please visit the application website

Application deadline: August 9, 2022

Link to Full Announcement: https://solve.mit.edu/challenges/performance-improvement#challenge-subnav-offset

 

Documents to download